Stock Events

Roche 

$39.43
1370
-$0.47-1.18% Wednesday 19:59

Statistics

Day High
39.53
Day Low
39.08
52W High
42.43
52W Low
29.2
Volume
179,558
Avg. Volume
1,422,121
Mkt Cap
272.83B
P/E Ratio
21.6
Dividend Yield
3.42%
Dividend
1.35

Upcoming

30
JAN 25
Earnings
 
14
MAR 25
Dividend Ex
Estimated
 
3
MAY 25
Dividend Payment
Estimated
 
14
MAR 26
Dividend Ex
Estimated
 
3
MAY 26
Dividend Payment
Estimated
 

Dividends

3.42%Dividend Yield
May 24
$1.35
Mar 23
$1.28
Mar 22
$1.24
Mar 21
$1.22
Mar 20
$1.14
10Y Growth
1.98%
5Y Growth
4.66%
3Y Growth
3.4%
1Y Growth
5.47%

Earnings

30JanExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
0
3.96
7.91
11.87
Expected EPS
9.5303955
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RHHBY. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap244.75B
Novartis competes directly with Roche in multiple areas including oncology, neuroscience, and immunology, making it a primary competitor.
Pfizer
PFE
Mkt Cap164.39B
Pfizer competes with Roche in the pharmaceutical sector, particularly in the development of cancer and immunology drugs.
Merck
MRK
Mkt Cap300.25B
Merck is a key competitor in the oncology space, directly competing with Roche's cancer drug portfolio.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson competes across a broad range of healthcare products, including pharmaceuticals that overlap with Roche's offerings.
Abbvie
ABBV
Mkt Cap346.75B
AbbVie competes in the biopharmaceutical field, particularly in areas like immunology and oncology, overlapping with Roche's interests.
AMGEN
AMGN
Mkt Cap179.38B
Amgen competes with Roche in the biotech sector, especially in cancer and hematology.
Bristol-Myers Squibb
BMY
Mkt Cap101.27B
Bristol Myers Squibb competes in the pharmaceutical and biopharmaceutical sectors, particularly in cancer, which is a key area for Roche.
GSK
GSK
Mkt Cap89.55B
GlaxoSmithKline competes with Roche in several areas including pharmaceuticals and vaccines.
Sanofi
SNY
Mkt Cap141.43B
Sanofi competes with Roche in the pharmaceutical sector, including treatments for rare diseases, which Roche also focuses on.
Astrazeneca
AZN
Mkt Cap271.67B
AstraZeneca competes with Roche in the development of drugs for various diseases, including cancer, respiratory, and cardiovascular diseases.

About

Pharmaceuticals: Major
Health Technology
Manufacturing
Medicinal and Botanical Manufacturing
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Show more...
CEO
Severin Schwan
Employees
103605
Country
US
ISIN
US7711951043

Listings

SW
CH
RO.SW
US
RHHBY
US
RHHVF
F
DE
RHO6.F